196 projects found matching your search criteria :
Call: PRELUDIUM 3 , Panel: NZ7
Principal investigator: dr Magdalena Anna Kolasa
Instytut Farmakologii PAN
Call: MAESTRO 3 , Panel: NZ4
Principal investigator: prof. Barbara Elżbieta Przewłocka
Instytut Farmakologii PAN
Call: SONATA 4 , Panel: NZ4
Principal investigator: dr Marta Ewa Kot
Instytut Farmakologii PAN
The role of the brain serotonergic system in the expression and activity of liver cytochrome P450.
Call: PRELUDIUM 4 , Panel: NZ7
Principal investigator: dr Marta Anna Rysz
Instytut Farmakologii PAN
Call: OPUS 4 , Panel: NZ4
Principal investigator: dr Maciej Sławomir Kuśmider
Instytut Farmakologii PAN
The role of kynurenine pathway in neurophatic pain in view of innovative treatment approaches
Call: SONATA 9 , Panel: NZ4
Principal investigator: dr Ewelina Joanna Rojewska
Instytut Farmakologii PAN
Call: PRELUDIUM 9 , Panel: NZ4
Principal investigator: Iwona Magdalena Majcher-Maślanka
Instytut Farmakologii PAN
Call: OPUS 9 , Panel: NZ7
Principal investigator: prof. Mariusz Papp
Instytut Farmakologii PAN
Call: HARMONIA 7 , Panel: NZ7
Principal investigator: Sabina Marta Podlewska
Instytut Farmakologii PAN
Call: PRELUDIUM 10 , Panel: NZ7
Principal investigator: Karolina Sylwia Podkowa
Instytut Farmakologii PAN
Call: OPUS 11 , Panel: NZ4
Principal investigator: prof. Joanna Gabriela Mika
Instytut Farmakologii PAN
Call: PRELUDIUM 11 , Panel: NZ4
Principal investigator: Michał Dariusz Rychlik
Instytut Farmakologii PAN
Call: PRELUDIUM 11 , Panel: NZ4
Principal investigator: Joanna Ewa Sowa
Instytut Farmakologii PAN
The role of halogen bonding in interaction of ligands with SERT.
Call: SONATA 11 , Panel: NZ7
Principal investigator: dr Jakub Staroń
Instytut Farmakologii PAN
Call: OPUS 12 , Panel: NZ7
Principal investigator: dr hab. Agnieszka Anna Nikiforuk
Instytut Farmakologii PAN
Call: PRELUDIUM 12 , Panel: NZ4
Principal investigator: Anna Katarzyna Solarz
Instytut Farmakologii PAN
Sensitivity to negative feedback as a cognitive biomarker of depression in an animal model
Call: OPUS 12 , Panel: NZ4
Principal investigator: dr hab. Rafał Ryguła
Instytut Farmakologii PAN
Call: OPUS 22 , Panel: NZ5
Principal investigator: prof. Małgorzata Maria Filip
Instytut Farmakologii PAN
Call: OPUS 22 , Panel: HS6
Principal investigator: dr hab. Rafał Ryguła
Instytut Farmakologii PAN
Cognitive impairment in chronic pain - CBD as the undervalued remedy.
Call: OPUS 22 , Panel: NZ7
Principal investigator: prof. Katarzyna Maria Starowicz-Bubak
Instytut Farmakologii PAN
Call: PRELUDIUM 21 , Panel: NZ7
Principal investigator: dr Magdalena Białoń
Instytut Farmakologii PAN
Call: OPUS 23 , Panel: NZ7
Principal investigator: prof. Władysława Anna Daniel
Instytut Farmakologii PAN
Call: PRELUDIUM 22 , Panel: NZ7
Principal investigator: Bernadeta Angelika Pietrzak-Wawrzyńska
Instytut Farmakologii PAN
The cross-talk between 5-HTR2A and mGluR2 as a window for antidepressant effects of psilocybin.
Call: OPUS 25 , Panel: NZ7
Principal investigator: prof. Andrzej Mikołaj Pilc
Instytut Farmakologii PAN
Call: OPUS 26 , Panel: NZ7
Principal investigator: prof. Mariusz Papp
Instytut Farmakologii PAN
Call: OPUS 27 , Panel: NZ7
Principal investigator: dr hab. Agata Faron-Górecka
Instytut Farmakologii PAN
Call: HARMONIA 9 , Panel: NZ7
Principal investigator: prof. Agnieszka Basta-Kaim
Instytut Farmakologii PAN
Call: PRELUDIUM 15 , Panel: NZ7
Principal investigator: dr Klaudia Kwiatkowski
Instytut Farmakologii PAN
Call: OPUS 16 , Panel: NZ7
Principal investigator: dr hab. Rafał Ryguła
Instytut Farmakologii PAN
Call: OPUS 16 , Panel: NZ2
Principal investigator: dr hab. Sabina Marta Podlewska
Instytut Farmakologii PAN
Call: OPUS 16 , Panel: NZ4
Principal investigator: prof. Marzena Małgorzata Maćkowiak
Instytut Farmakologii PAN
Call: PRELUDIUM 16 , Panel: NZ7
Principal investigator: dr Paulina Agnieszka Cieślik
Instytut Farmakologii PAN
Call: OPUS 18 , Panel: NZ7
Principal investigator: dr hab. Katarzyna Zofia Kuter-Nowak
Instytut Farmakologii PAN
Call: SONATA 15 , Panel: NZ7
Principal investigator: dr Piotr Chmielarz
Instytut Farmakologii PAN
Fluorine substitution – a new algorithm for increasing biological activity
Call: PRELUDIUM 18 , Panel: NZ7
Principal investigator: Wojciech Pietruś
Instytut Farmakologii PAN
Call: SONATINA 4 , Panel: NZ7
Principal investigator: Katarzyna Anna Szczepańska
Instytut Farmakologii PAN
Call: OPUS 22 , Panel: NZ5
Principal investigator: dr Dawid Mateusz Gawliński
Instytut Farmakologii PAN
Call: OPUS 22 , Panel: NZ7
Principal investigator: prof. Joanna Gabriela Mika
Instytut Farmakologii PAN
The role of the immune checkpoints in the pathomechanism of depressive disorders.
Call: OPUS 22 , Panel: NZ6
Principal investigator: prof. Marta Wanda Kubera
Instytut Farmakologii PAN
Call: OPUS 5 , Panel: NZ7
Principal investigator: prof. Agnieszka Basta-Kaim
Instytut Farmakologii PAN
Call: PRELUDIUM 6 , Panel: NZ7
Principal investigator: Anna Maria Górska
Instytut Farmakologii PAN
Call: OPUS 6 , Panel: NZ4
Principal investigator: prof. Grzegorz Władysław Hess
Instytut Farmakologii PAN
Call: SONATA 7 , Panel: NZ7
Principal investigator: dr Katarzyna Małgorzata Stachowicz
Instytut Farmakologii PAN
Call: PRELUDIUM 8 , Panel: NZ7
Principal investigator: Agnieszka Teresa Potasiewicz
Instytut Farmakologii PAN
Call: PRELUDIUM 8 , Panel: NZ4
Principal investigator: Przemysław Eligiusz Cieślak
Instytut Farmakologii PAN
seQinspector - genome-wide analysis of gene transcription regulation mechanisms
Call: PRELUDIUM 1 , Panel: NZ2
Principal investigator: dr Marcin Piechota
Instytut Farmakologii PAN